Clinical Trials

Phase 3 Active not recruiting

370 enrolled 17 charts

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04557059 2026-04-13

PRIMORDIUM

693 enrolled

Genitourinary

Prostatic Neoplasms

NCT04892173 2026-03-13

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Phase 3 Recruiting

500 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05415215 2026-02-10

ProHer

346 enrolled 20 charts

Breast

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

NCT03040999 2026-02-04

KEYNOTE-412

804 enrolled 20 charts

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03725059 2025-07-11

KEYNOTE-756

1,240 enrolled

Breast

Breast Neoplasms

NCT02667587 2025-06-18

CheckMate548

716 enrolled 15 charts

Brain Neoplasms

NCT01345084 2025-03-28

NICAP

Phase 3 Withdrawn

Phase 3 Active not recruiting

Carcinoma, Head and Neck Neoplasms

NCT04210115 2024-11-15

KEYNOTE 975

703 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

NCT04866017 2024-10-31

A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer

Phase 3 Terminated

63 enrolled 15 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03776071 2024-04-22

A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

260 enrolled

Glioblastoma

NCT02617589 2023-03-28

CheckMate 498

560 enrolled 14 charts

Brain Neoplasms

NCT01265849 2022-08-19

IT-MATTERS

928 enrolled 25 charts

Squamous Cell Carcinoma of Head and Neck

NCT00005887 2021-08-23

Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases

Brain Neoplasms, Neoplasm Metastasis

NCT03349710 2021-08-09

Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer

74 enrolled 19 charts

Squamous Cell Carcinoma of Head and Neck

NCT04203511 2020-06-09

INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)

Phase 3 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00943826 2017-09-25

A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma

921 enrolled 14 charts

Glioblastoma

NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

188 enrolled 19 charts

Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

NCT01122121 2015-07-29

Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer

273 enrolled

Genitourinary

Prostatic Neoplasms

NCT00689221 2014-11-04

CENTRIC

545 enrolled 17 charts

Glioblastoma

NCT02183246 2014-07-08

Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients

Phase 3 Terminated

3 enrolled

Head and Neck Neoplasms

NCT00055887 2013-05-10

Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase 3 Withdrawn

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00615186 2011-02-10

Glass-Art

Phase 3 Terminated

9 enrolled

Glioblastoma

NCT00094081 2010-02-15

Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer

861 enrolled